Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 700167

Adding external beam to intra-luminal brachytherapy improves palliation in obstructive squamous cell oesophageal cancer: A prospective multi-centre randomized trial of the International Atomic Energy Agency


Rosenblatt, Eduardo; Jones, Glenn; Sur, Ranjan K.; Donde, Bernard; Salvajoli, Joao V.; Ghosh-Laskar, Sarbani; Fröbe, Ana; Suleiman, Ahmed; Xiao, Zafen; Nag, Subir
Adding external beam to intra-luminal brachytherapy improves palliation in obstructive squamous cell oesophageal cancer: A prospective multi-centre randomized trial of the International Atomic Energy Agency // Radiotherapy and oncology, 97 (2010), 3; 488-494 doi:10.1016/j.radonc.2010.09.001 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 700167 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Adding external beam to intra-luminal brachytherapy improves palliation in obstructive squamous cell oesophageal cancer: A prospective multi-centre randomized trial of the International Atomic Energy Agency

Autori
Rosenblatt, Eduardo ; Jones, Glenn ; Sur, Ranjan K. ; Donde, Bernard ; Salvajoli, Joao V. ; Ghosh-Laskar, Sarbani ; Fröbe, Ana ; Suleiman, Ahmed ; Xiao, Zafen ; Nag, Subir

Izvornik
Radiotherapy and oncology (0167-8140) 97 (2010), 3; 488-494

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
radiotherapy; brahytherapy; oesophageal cancer

Sažetak
Background: Whether the combination of high dose-rate brachytherapy (HDRBT) and External Beam Radiation Therapy (EBRT) is superior to HDRBT alone for the palliation of oesophageal cancer has only been explored in a previous IAEA pilot randomized trial. Methods: Two hundred and nineteen patients were randomized to adding EBRT or not, after receiving two fractions of HDRBT within 1 week. Each HDRBT consisted of 8 Gy prescribed at 1 cm from source centre. Patients randomized to EBRT received 30 Gy in 10 fractions. The primary outcome was dysphagia-relief experience (DRE). Additional outcomes included various scores, performance status, weight and adverse events. A majority of charts, imaging and radiotherapy plans were externally audited. Results: Median follow-up was 197 days, with a median OS of 188 days and an 18% survival rate at 1 year. DRE was significantly improved with combined therapy, for an absolute benefit of +18% at 200 days from randomization (p = 0.019). In longitudinal regression analyses, scores for dysphagia (p = 0.00005), odynophagia (p = 0.006), regurgitation (p = 0.00005), chest pain (p = 0.0038) and performance status (p = 0.0015) were all significantly improved. In contrast, weight, toxicities and overall survival were not different between study arms. Conclusion: Symptom improvement occurs with the addition of EBRT to standard HDRBT. The combination is well tolerated and relatively safe.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Medicinski fakultet, Zagreb

Profili:

Avatar Url Ana Fröbe (autor)

Poveznice na cjeloviti tekst rada:

doi www.sciencedirect.com www.ncbi.nlm.nih.gov

Citiraj ovu publikaciju:

Rosenblatt, Eduardo; Jones, Glenn; Sur, Ranjan K.; Donde, Bernard; Salvajoli, Joao V.; Ghosh-Laskar, Sarbani; Fröbe, Ana; Suleiman, Ahmed; Xiao, Zafen; Nag, Subir
Adding external beam to intra-luminal brachytherapy improves palliation in obstructive squamous cell oesophageal cancer: A prospective multi-centre randomized trial of the International Atomic Energy Agency // Radiotherapy and oncology, 97 (2010), 3; 488-494 doi:10.1016/j.radonc.2010.09.001 (međunarodna recenzija, članak, znanstveni)
Rosenblatt, E., Jones, G., Sur, R., Donde, B., Salvajoli, J., Ghosh-Laskar, S., Fröbe, A., Suleiman, A., Xiao, Z. & Nag, S. (2010) Adding external beam to intra-luminal brachytherapy improves palliation in obstructive squamous cell oesophageal cancer: A prospective multi-centre randomized trial of the International Atomic Energy Agency. Radiotherapy and oncology, 97 (3), 488-494 doi:10.1016/j.radonc.2010.09.001.
@article{article, author = {Rosenblatt, Eduardo and Jones, Glenn and Sur, Ranjan K. and Donde, Bernard and Salvajoli, Joao V. and Ghosh-Laskar, Sarbani and Fr\"{o}be, Ana and Suleiman, Ahmed and Xiao, Zafen and Nag, Subir}, year = {2010}, pages = {488-494}, DOI = {10.1016/j.radonc.2010.09.001}, keywords = {radiotherapy, brahytherapy, oesophageal cancer}, journal = {Radiotherapy and oncology}, doi = {10.1016/j.radonc.2010.09.001}, volume = {97}, number = {3}, issn = {0167-8140}, title = {Adding external beam to intra-luminal brachytherapy improves palliation in obstructive squamous cell oesophageal cancer: A prospective multi-centre randomized trial of the International Atomic Energy Agency}, keyword = {radiotherapy, brahytherapy, oesophageal cancer} }
@article{article, author = {Rosenblatt, Eduardo and Jones, Glenn and Sur, Ranjan K. and Donde, Bernard and Salvajoli, Joao V. and Ghosh-Laskar, Sarbani and Fr\"{o}be, Ana and Suleiman, Ahmed and Xiao, Zafen and Nag, Subir}, year = {2010}, pages = {488-494}, DOI = {10.1016/j.radonc.2010.09.001}, keywords = {radiotherapy, brahytherapy, oesophageal cancer}, journal = {Radiotherapy and oncology}, doi = {10.1016/j.radonc.2010.09.001}, volume = {97}, number = {3}, issn = {0167-8140}, title = {Adding external beam to intra-luminal brachytherapy improves palliation in obstructive squamous cell oesophageal cancer: A prospective multi-centre randomized trial of the International Atomic Energy Agency}, keyword = {radiotherapy, brahytherapy, oesophageal cancer} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font